Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Syneos Health Inc (SYNH)

Syneos Health Inc (SYNH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,337,080
  • Shares Outstanding, K 104,220
  • Annual Sales, $ 4,416 M
  • Annual Income, $ 192,790 K
  • 60-Month Beta 1.82
  • Price/Sales 1.86
  • Price/Cash Flow 15.63
  • Price/Book 2.52
Trade SYNH with:

Options Overview

Details
  • Implied Volatility 48.08%
  • Historical Volatility 28.21%
  • IV Percentile 39%
  • IV Rank 16.19%
  • IV High 125.73% on 04/13/20
  • IV Low 33.08% on 11/06/20
  • Put/Call Vol Ratio 105.00
  • Today's Volume 106
  • Volume Avg (30-Day) 64
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 113
  • Open Int (30-Day) 872

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.62
  • Number of Estimates 4
  • High Estimate 0.63
  • Low Estimate 0.61
  • Prior Year 0.56
  • Growth Rate Est. (year over year) +10.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
73.23 +8.08%
on 03/15/21
80.31 -1.44%
on 04/09/21
+5.35 (+7.25%)
since 03/12/21
3-Month
69.53 +13.84%
on 03/05/21
81.35 -2.70%
on 02/16/21
+4.54 (+6.08%)
since 01/12/21
52-Week
46.27 +71.06%
on 04/15/20
81.35 -2.70%
on 02/16/21
+29.54 (+59.54%)
since 04/09/20

Most Recent Stories

More News
Matsuyama Makes History with Green Jacket at Augusta; DraftKings and DGTL Winners at Masters Too

The 2021 PGA Masters golf tournament in Augusta, Georgia had all the usual thrills that give it a global ...

DGTL.VN : 0.650 (unch)
PEP : 143.02 (+0.32%)
BUD : 65.07 (-0.49%)
YUM : 116.42 (+1.27%)
KDP : 35.49 (+0.91%)
TJX : 69.52 (+0.10%)
VERI : 24.47 (+0.16%)
SYNH : 79.15 (-1.06%)
DKNG : 58.03 (-6.87%)
DGTHF : 0.5300 (+6.00%)
Syneos Health Schedules First Quarter 2021 Earnings Call for Thursday, April 29, 2021

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its first quarter 2021 financial results on Thursday, April 29, 2021, prior to its earnings...

SYNH : 79.15 (-1.06%)
Reasons to Hold on to Syneos Health (SYNH) Stock For Now

Investors continue to be optimistic about Syneos Health (SYNH) on solid sequential recovery of its operating segments and strategic partnerships.

HAE : 116.58 (-0.41%)
ALGN : 601.11 (+1.44%)
IDXX : 506.43 (+0.71%)
SYNH : 79.15 (-1.06%)
Syneos Health (SYNH) New Partnership to Enhance Clinical Trials

Syneos Health (SYNH) new partnership will extend the company's mission to boost research and enable universal patient and provider access with clinical research services.

OMI : 36.76 (+0.16%)
SYNH : 79.15 (-1.06%)
INMD : 82.78 (+2.59%)
NVST : 41.76 (-1.23%)
Syneos Health Partners with Science 37(R) to Transform Clinical Trials - Increasing Speed and Diversity

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Science 37, the industry's only Decentralized Clinical Trial Operating System(TM), today announced a...

SYNH : 79.15 (-1.06%)
Why Is Syneos Health (SYNH) Up 4.1% Since Last Earnings Report?

Syneos Health (SYNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

SYNH : 79.15 (-1.06%)
Syneos Health Communications Boosts Global Creative Capabilities with Renowned Talent

Syneos Health Communications - the portfolio of Syneos Health agencies designed to deliver insights-driven integrated communications spanning advertising, public relations, patient advocacy, medical communications,...

SYNH : 79.15 (-1.06%)
Syneos Health Announces Pricing of Secondary Offering of Common Stock

Syneos Health, Inc. (Nasdaq: SYNH) (the "Company" or "Syneos Health"), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract...

SYNH : 79.15 (-1.06%)
Syneos Health Announces Secondary Offering of Common Stock

Syneos Health, Inc. (Nasdaq: SYNH) (the "Company" or "Syneos Health"), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract...

SYNH : 79.15 (-1.06%)
Syneos Health and Protocol First Partner to Accelerate Collection and Review of Clinical Trial Data

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Protocol First, Inc., a software solutions provider focused on accelerating clinical research, today...

SYNH : 79.15 (-1.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Syneos Health Inc. is an integrated biopharmaceutical solutions organization. It includes a Contract Research Organization and Contract Commercial Organization to accelerate customer performance to address modern market realities. Syneos Health Inc., formerly known as INC Research Holdings Inc., is based...

See More

Key Turning Points

3rd Resistance Point 81.08
2nd Resistance Point 80.69
1st Resistance Point 79.92
Last Price 79.15
1st Support Level 78.76
2nd Support Level 78.37
3rd Support Level 77.60

See More

52-Week High 81.35
Last Price 79.15
Fibonacci 61.8% 67.95
Fibonacci 50% 63.81
Fibonacci 38.2% 59.67
52-Week Low 46.27

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar